NASDAQ:CYBECyberOptics Stock Price, Forecast & News

CyberOptics' stock was trading at $16.85 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, CYBE stock has increased by 98.0% and is now trading at $33.36. View which stocks have been most impacted by Coronavirus.

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for CyberOptics in the last year. There are currently 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for CyberOptics.

CyberOptics is scheduled to release its next quarterly earnings announcement on Wednesday, July 22nd 2020. View our earnings forecast for CyberOptics.

CyberOptics Co. (NASDAQ:CYBE) announced its quarterly earnings data on Thursday, April, 23rd. The scientific and technical instruments company reported $0.11 earnings per share (EPS) for the quarter, beating the Zacks' consensus estimate of $0.02 by $0.09. The scientific and technical instruments company earned $16.43 million during the quarter. CyberOptics had a return on equity of 1.93% and a net margin of 1.85%. View CyberOptics' earnings history.

CyberOptics issued an update on its second quarter 2020 After-Hours earnings guidance on Thursday, April, 23rd. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $15.5-17.5 million, compared to the consensus revenue estimate of $15.76 million.

2 equities research analysts have issued twelve-month target prices for CyberOptics' shares. Their forecasts range from $27.00 to $33.00. On average, they expect CyberOptics' stock price to reach $30.00 in the next twelve months. This suggests that the stock has a possible downside of 10.1%. View analysts' price targets for CyberOptics.

Press coverage about CYBE stock has trended very negative on Friday, according to InfoTrie Sentiment Analysis. The research firm identifies negative and positive press coverage by reviewing more than six thousand blog and news sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores closest to five being the most favorable. CyberOptics earned a coverage optimism score of -3.2 on InfoTrie's scale. They also gave press coverage about the scientific and technical instruments company a news buzz of 10.0 out of 10, indicating that recent press coverage is extremely likely to have an impact on the company's share price in the next few days. View the latest news aboutCyberOptics.

CyberOptics saw a decrease in short interest in May. As of May 15th, there was short interest totaling 139,200 shares, a decrease of 7.2% from the April 30th total of 150,000 shares. Based on an average daily trading volume, of 68,400 shares, the days-to-cover ratio is presently 2.0 days. Currently, 2.0% of the shares of the stock are short sold. View CyberOptics' Current Options Chain.

Some companies that are related to CyberOptics include KLA (KLAC), II-VI (IIVI), Nova Measuring Instruments (NVMI), Topcon (TOPCF), Camtek (CAMT), Perceptron (PRCP), Optex Systems Hldg InCorp (OPXS) and ProPhotonix (STKR). View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other CyberOptics investors own include Alibaba Group (BABA), Baidu (BIDU), Canopy Growth (CGC), Netflix (NFLX), NVIDIA (NVDA), Ring Energy (REI), Ring Energy (REI), Tesla (TSLA), Aphria (APHA) and DexCom (DXCM).

CyberOptics trades on the NASDAQ under the ticker symbol "CYBE."

CyberOptics' stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Wellington Management Group LLP (6.09%), Epiq Partners LLC (1.45%), Penbrook Management LLC (1.05%), Acadian Asset Management LLC (1.04%), Geode Capital Management LLC (0.86%) and Russell Investments Group Ltd. (0.72%). View institutional ownership trends for CyberOptics.

CYBE stock was sold by a variety of institutional investors in the last quarter, including Wellington Management Group LLP, Penbrook Management LLC, JPMorgan Chase & Co., UBS Group AG, Alambic Investment Management L.P., and White Pine Capital LLC. View insider buying and selling activity for CyberOptics.

CYBE stock was acquired by a variety of institutional investors in the last quarter, including Russell Investments Group Ltd., EAM Investors LLC, Acadian Asset Management LLC, Assenagon Asset Management S.A., Wedge Capital Management L L P NC, Geode Capital Management LLC, Epiq Partners LLC, and Morgan Stanley. View insider buying and selling activity for CyberOptics.

Shares of CYBE can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of CYBE stock can currently be purchased for approximately $33.36.

CyberOptics has a market capitalization of $239.42 million and generates $59.26 million in revenue each year. The scientific and technical instruments company earns $770,000.00 in net income (profit) each year or $0.11 on an earnings per share basis. CyberOptics employs 178 workers across the globe.

The official website for CyberOptics is www.cyberoptics.com.

CyberOptics' mailing address is 5900 GOLDEN HILLS DRIVE, MINNEAPOLIS MN, 55416. The scientific and technical instruments company can be reached via phone at 763-542-5000 or via email at [email protected]